You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for Patent: 5,217,974


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,217,974
Title: Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
Abstract:Administration of a folate binding protein binding agent in conjunction with use of an antitumor agent which is an inhibitor of glycinamide ribonucleotide transformylase or other antifolate reduces the toxic effects of such agent and provides an enhanced therapeutic index.
Inventor(s): Grindey; Gerald B. (Indianapolis, IN), Shih; Chuan (Carmel, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:07/940,568
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,217,974

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,217,974

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 126700 ⤷  Sign Up
Australia 640524 ⤷  Sign Up
Australia 8457091 ⤷  Sign Up
Canada 2051520 ⤷  Sign Up
Cyprus 1888 ⤷  Sign Up
Germany 69112376 ⤷  Sign Up
Denmark 0505640 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.